Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,162Revenue (TTM) $M1,528Net Margin (%)26.8Altman Z-Score2.9
Enterprise Value $M10,517EPS (TTM) $6.6Operating Margin %39.7Piotroski F-Score7
P/E(ttm)22.7Beneish M-Score-2.5Pre-tax Margin (%)35.4Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsY
Price/Sales6.15-y EBITDA Growth Rate %28.9Current Ratio1.9Lower Leverage y-yN
Price/Free Cash Flow21.4y-y EBITDA Growth Rate %20.2ROA % (ttm)9.5Higher Current Ratio y-yN
Dividend Yield %--PEG1.0ROE % (ttm)23.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M60.0ROIC % (ttm)16.1Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

JAZZ is held by these investors:



JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MILLER MICHAEL PATRICKEVP, US Commercial 2017-05-15Sell200$152.98-0.61view
COZADD BRUCE CChairman & CEO 2017-05-11Sell30,000$153.47-0.93view
Hooper Suzanne SawochkaEVP & General Counsel 2017-05-09Sell2,500$160-4.97view
WILSON KAREN JSVP, Finance & PAO 2017-04-27Sell1,275$160-4.97view
Hooper Suzanne SawochkaEVP & General Counsel 2017-04-27Sell2,500$160-4.97view
MILLER MICHAEL PATRICKSVP, US Commercial 2017-04-17Sell200$152.56-0.33view
COZADD BRUCE CChairman & CEO 2017-04-11Sell1,000$152.12-0.05view
WILSON KAREN JSVP, Finance & PAO 2017-04-10Sell11,458$152.24-0.12view
MILLER MICHAEL PATRICKSVP, US Commercial 2017-03-15Sell200$137.8910.27view
Treacy PaulSVP, Technical Operations 2017-03-06Sell884$131.9715.22view

Quarterly/Annual Reports about JAZZ:

News about JAZZ:

Articles On GuruFocus.com
Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS May 24 2017 
Jazz Pharmaceuticals to Present Phase 3 Data on JZP-110, an Investigational Treatment for Excessive May 24 2017 
Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences May 16 2017 
Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 2 Study of JZP-110 in Narcole Apr 26 2017 
Jazz Pharmaceuticals to Report 2017 First Quarter Financial Results on May 9, 2017 Apr 25 2017 
Jazz Pharmaceuticals Announces Positive Results from the Phase 2/3 EXPRESS Study of Xyrem in Pediatr Apr 24 2017 
Jazz Pharmaceuticals Reaches Settlement with Hikma Pharmaceuticals Related to Xyrem Patent Litigatio Apr 05 2017 
Jazz Pharmaceuticals Completes Rolling Submission of New Drug Application for Vyxeos™ (CPX-351), a Apr 03 2017 
Jazz Pharmaceuticals and Nippon Shinyaku Enter Into License Agreements for the Development and Comme Mar 31 2017 
Cellectar Biosciences' PDC Delivery Platform May Advance Treatment of Multiple Myeloma Feb 13 2017 

More From Other Websites
Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS May 24 2017
Jazz Pharmaceuticals to Present Phase 3 Data on JZP-110, an Investigational Treatment for Excessive... May 24 2017
BioLineRx Makes Regulatory Submission for Trial of BL-8040 May 23 2017
ETFs with exposure to Jazz Pharmaceuticals Plc : May 22, 2017 May 22 2017
3 Value Stocks for Ambitious Investors May 21 2017
Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 May 19 2017
Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : JAZZ-US : May 18,... May 18 2017
Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences May 16 2017
Edited Transcript of JAZZ earnings conference call or presentation 9-May-17 8:30pm GMT May 15 2017
4 of the Cheapest Biotech Stocks in the World May 10 2017
Jazz Pharmaceuticals (JAZZ) Misses Q1 Earnings & Sales May 10 2017
Jazz misses Street 1Q forecasts May 09 2017
Jazz Pharma Reports Lagging First-Quarter Sales, Profits May 09 2017
Jazz Pharmaceuticals Announces First Quarter 2017 Financial Results May 09 2017
Investor Network: Jazz Pharmaceuticals Plc to Host Earnings Call May 09 2017
Allergan's Q1 Sales Expected To Slip As Jazz Pharma Outperforms May 08 2017
4 Medical Stocks That Could Be Big Winners Next Week May 05 2017
Jazz Pharma (JAZZ) Q1 Earnings: Stock Likely to Disappoint? May 03 2017
3 Top Biotech Stocks to Buy Now Apr 29 2017
Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 2 Study of JZP-110 in... Apr 26 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)